Top Takeaways from Boston Business Journal’s Biotech in Boston: Leading the Way in Life Sciences
Boston is a leader in the biotech and life sciences industries and the home of one of the largest hubs of scientific innovation in the world. This key sector of our local economy is fueled by local talent and resources in our region, including lab space expansion, a hot real estate market and a large share of overall national VC investments.
Boston Business Journal recently hosted Biotech in Boston, an event featuring dynamic panel discussions in which industry leaders and change makers shared their insights on topics including M&A and IPO activity and the state of real estate and biotech. As PR practitioners, we’re always following the latest trends in biotech and life sciences for our clients, and this was a great way to hear directly from experts who work in this space for the latest and greatest.
Read on for top takeaways from panel discussions, the latest on innovation and growth of biotech and life sciences industries and why they are critical to our local economy:
Investors optimistic yet cautious amidst upcoming election:
So far in 2024, two Massachusetts life sciences companies have seen initial public offerings. There were only two in all of 2023. With five months left to go in 2024, time will tell if the IPO market in Massachusetts will surpass last year. There’s no question that the IPO scene is quiet compared to what it looked like just a few years ago but despite a challenging time for biotech companies, industry leaders are hopeful for a strong second half of 2024 and beyond.
According to a panel of industry experts including Stephanie Richards, an Attorney at Goodwin, Dr. Harith Rajagopalan, the CEO of Fractyl, and Gabriel Cavazos, Senior Managing Director of Biotechnology at Leerink Partners, there are certain key areas that investors in pharma are focused on, like the next big blockbuster drug in the autoimmune space. The pendulum also swung back in the cardiometabolic space with investors showing increasing interest, and the rare disease and oncology spaces are still important but not garnering as much attention from investors as they were a few years ago.
The impending election is now more front and center than ever. Investors are eyeing interest rates and are also concerned about what this upcoming election is going to mean for healthcare and the FDA, specifically when it comes to the Inflation Reduction Act (IRA) and drug pricing.
Location, location, location – Biotech in and around Boston is booming:
The density of companies in Boston is unrivaled; and the overall ecosystem including R&D, sales analysts and traders all being in the city is also a major advantage. Being close to the action is important – and there’s a lot of it in and around Boston!
Cambridge is known for being a biotech hub, but on a panel featuring industry experts including Jeff Myers, Research Director at Colliers, Bob Richards, Executive Managing Director at JLL and Jessica Hughes, Managing Director/Regional Director, Boston D.C. at Tishman Speyer – they noted Allston and Brighton have also been popping up in a way they haven’t been before (stay tuned for more on a new lab in Allston from our client BioBuilder this year!) and clusters are also popping up along the route 128 corridor including Waltham. Watertown also continues to be an appealing space, and construction is underway in Somerville.
According to panelists, top priorities for biotech and life sciences companies include where they can get the best talent, how they can use their real estate to attract that talent and where to find access to the best housing and transportation. Though the demand is lower compared to a few years ago, Massachusetts continues to be a hot real estate hub for biopharma companies.
While there were many great takeaways from Boston Business Journal’s Biotech in Boston event, one main thing is clear – the Bay State continues to be at the forefront of innovation in biotech and life sciences, with drug development accounting for 14.9% of the U.S. pipeline. We’ll continue to keep a close eye on the biotech ecosystem here in Boston to provide valuable market insights for our clients and share opportunities for growth.
What our clients say
Ameresco
Leila Dillon, SVP, Corporate Marketing and Communications
It's clear that the Greenough Communications team has a deep understanding of the clean tech and climate transition spaces. Within the first month of working together, they were able to land interviews with The Washington Post, The New York Times and Canary Media, just to name a few! Since working together, we've seen our media coverage and quality increase significantly across the board. We value Greenough's partnership are looking forward to our continued work together.
Boston Micro Fabrication
Laura Galloway, Marketing Director
As a small marketing team, having an agency partner that feels like a true extension of my team is invaluable. The Greenough Communications team is professional, responsive and has taken the time to understand our business, putting our brand in front of the customers who matter for our growth. I’ve been very happy with our first year of partnership and look forward to future success.
Acrolinx
Mariana Just, Vice President, Marketing
We started working with Greenough Communications over a year ago, and it's been a fantastic journey. They really understand who we are at Acrolinx and what we want to say. Their ability to amplify our message in a crowded AI space has been impressive, delivering solid media results in the outlets that matter, securing the AI Breakthrough Award, and boosting our executive team's social media presence. As we continue our partnership, we're excited about expanding our reach and market presence, building upon our refreshed positioning and messaging with Greenough's expertise guiding us every step of the way.
IQE
Steven Curwood, Director of Corporate Marketing
At IQE, one of our goals is to demystify the vital role compound semiconductors play in the industry and the future of innovation. As we aim to broaden our brand's reach in the U.S. market, finding an agency that understands our technology and the intricacies of our work is crucial. Greenough Communications stood out as that agency from the start. In the short time we've worked together, they've already validated our choice with opportunities in key media, including CNBC, NPR, and the U.S. trade media that will move the needle for our brand and message. There's much ahead for us, and we're excited to have the Greenough team by our side.
Arbella Insurance
John Donohue, CEO
Our Greenough team has excelled in learning our business and our challenges and has been extremely effective in developing and executing a PR strategy that helps drive our success.
Wolters Kluwer Health
André Rebelo, Global Marketing Communications & Public Relations
Our Greenough team has been a strategic asset in sustaining targeted growth in our PR and external communications. The team really operates like an extension of our internal team, aligned and effective. They've deftly balanced the needs of multiple sub-groups' objectives and needs, getting great results in the publications our customers read.
GlobalFoundries
Laurie Kelly, Chief Communications Officer
Greenough Communications has been more than just a PR agency for us at GlobalFoundries; they've been true partners. From navigating our IPO to driving impactful education campaigns like the one leading up to the passage of the CHIPS Act, they've been instrumental in showing the world our leadership role in this new technology era. Their knack for building connections with the industry and our team, including our executives, has been impressive. Every year, we throw new challenges their way, and they keep delivering. As we move ahead together, we're excited to keep pushing the boundaries, sharpening our brand narrative, and taking our brand awareness to the next level.
Integrated Marketing
Content Development
Public Relations
Brand Strategy
Integrated Marketing
Content Development
Public Relations
Brand Strategy
Public Relations
Brand Strategy
Integrated Marketing
Content Development
Public Relations
Brand Strategy
Integrated Marketing
Content Development
Let's start a project together.
